Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
Clinical trial NCT02189174 · TERMINATED
Trial details
- NCT number
- NCT02189174
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-07
- Primary completion
- 2015-11-12
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.